Study | Country Study period |
Population source | Exposure definition | Non-exposure definition | Sample size | Rmk |
---|---|---|---|---|---|---|
Weber-Schoendorfer, 2008 |
Finland, France, Germany, Israel, Italy, the Netherlands. 1986 - 2003 |
Pregnant women who or whose physician contacted a Teratology Information Service (TIS) in regard to exposure to chemicals or drugs during pregnancy. | Pregnant women with first- trimester exposure to Nifedipine. |
unexposed (general population or NOS)
Pregnant women who had been counseled during pregnancy about exposures known to be non-teratogenic. |
76 / 806 |
Study | Country Study period |
Case | Control | Sample size | Rmk |
---|---|---|---|---|---|
Vermes, 2015 |
Hungary 1980 - 1996 |
Newborn infants (including infant deaths and usual stillborn fetuses) with isolated Oesophageal Atresia. | Newborn infants (including infant deaths and usual stillborn fetuses) without congenital abnormalities. | 221 / 356 | Study design completed with other studies published on the Hungarian Case-Control Surveillance of Congenital Abnormalities (HCCSCA). Cases with multiple/syndromic Oesophageal Atresia were excluded from the study. |
Zarante, 2009 |
Colombia 2001- 2006 |
All newborns and stillborns of weight >500 g that presented only one craniofacial malformation, not associated with any other congenital condition. | The next non-malformed same sex child born in the same hospital. | 374 / 728 | Exclusion of patients with Down syndrome, Potter sequence, VACTERL association, and other unspecified multiple malformations. |